Transient massive trimethylaminuria associated with food protein-induced enterocolitis syndrome
- PMID: 23821320
- PMCID: PMC3897788
- DOI: 10.1007/8904_2013_238
Transient massive trimethylaminuria associated with food protein-induced enterocolitis syndrome
Abstract
Trimethylaminuria (TMAU) is an autosomal recessive disease caused by excessive excretion into body fluids and breath of unoxidized trimethylamine (TMA) derived from the enterobacterial metabolism of dietary precursors. The condition is caused by deficiency of flavin-containing monooxygenase 3 (FMO3) which leads to impairment of hepatic TMA oxidation to the odorless trimethylamine N-oxide. Secondary TMAU is due to substrate overload in individuals with genetically determined reduced enzyme activity. Food protein-induced enterocolitis syndrome (FPIES) is characterized by recurrent episodes of emesis, diarrhea, dehydration, and lethargy after ingestion of offending foods. Its pathophysiology involves local non-IgE-mediated inflammation of the gastrointestinal tract, which leads to increased intestinal permeability. We report on an 8-month-old male who presented with typical episodes of FPIES associated with intense fish-like body odor. Further investigation in our patient revealed massive urinary TMA excretion during acute FPIES presentation and complete normalization between these episodes. The patient was found to be heterozygous for a novel, paternally inherited nonsense p.Tyr331X mutation and for two maternally inherited common polymorphisms, E158K and E308G, in the FMO3 gene. We propose that our patient was able to cope with the daily burden of TMA, but when challenged with substrate overload, he failed to oxidize TMA due to limited reserve enzyme capacity. We discuss the pathophysiology of TMAU and FPIES and suggest potential mechanisms for the clinical and biochemical findings. Our report illustrates the complex interplay of genetic and environmental factors in TMAU and sheds light on the pathophysiology of FPIES.
Similar articles
-
Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.Mol Genet Metab. 2009 Jun;97(2):128-35. doi: 10.1016/j.ymgme.2009.02.006. Epub 2009 Feb 27. Mol Genet Metab. 2009. PMID: 19321370 Free PMC article.
-
Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.Gene. 2013 Sep 15;527(1):366-70. doi: 10.1016/j.gene.2013.05.025. Epub 2013 Jun 17. Gene. 2013. PMID: 23791655
-
Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.J Inherit Metab Dis. 2006 Feb;29(1):162-72. doi: 10.1007/s10545-006-0158-6. J Inherit Metab Dis. 2006. PMID: 16601883 Clinical Trial.
-
Treatments of trimethylaminuria: where we are and where we might be heading.Drug Discov Today. 2020 Sep;25(9):1710-1717. doi: 10.1016/j.drudis.2020.06.026. Epub 2020 Jun 29. Drug Discov Today. 2020. PMID: 32615074 Review.
-
Trimethylamine: metabolic, pharmacokinetic and safety aspects.Curr Drug Metab. 2005 Jun;6(3):227-40. doi: 10.2174/1389200054021807. Curr Drug Metab. 2005. PMID: 15975041 Review.
Cited by
-
The Effects of Diet, Dietary Supplements, Drugs and Exercise on Physical, Diagnostic Values of Urine Characteristics.Nutrients. 2024 Sep 17;16(18):3141. doi: 10.3390/nu16183141. Nutrients. 2024. PMID: 39339741 Free PMC article. Review.
-
Microbiota and Malodor-Etiology and Management.Int J Mol Sci. 2020 Apr 20;21(8):2886. doi: 10.3390/ijms21082886. Int J Mol Sci. 2020. PMID: 32326126 Free PMC article. Review.
-
Adaptive Modelling of Mutated FMO3 Enzyme Could Unveil Unexplored Scenarios Linking Variant Haplotypes to TMAU Phenotypes.Molecules. 2021 Nov 22;26(22):7045. doi: 10.3390/molecules26227045. Molecules. 2021. PMID: 34834137 Free PMC article.
-
Differential diagnosis of food protein-induced enterocolitis syndrome.Curr Opin Allergy Clin Immunol. 2014 Jun;14(3):246-54. doi: 10.1097/ACI.0000000000000057. Curr Opin Allergy Clin Immunol. 2014. PMID: 24739227 Free PMC article. Review.
-
Pathogenic Mechanisms of Trimethylamine N-Oxide-induced Atherosclerosis and Cardiomyopathy.Curr Vasc Pharmacol. 2022;20(1):29-36. doi: 10.2174/1570161119666210812152802. Curr Vasc Pharmacol. 2022. PMID: 34387163 Free PMC article.
References
-
- Chung HL, Hwang JB, Park JJ, Kim SG. Expression of transforming growth factor b1, transforming growth factor type I and II receptors, and TNF-a in the mucosa of the small intestine in infants with food protein-induced enterocolitis syndrome. J Allergy Clin Immunol. 2002;109(1):150–154. doi: 10.1067/mai.2002.120562. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources